ArticleESMO open2023

Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastases.

J R Hecht et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.